https://ir.viraxbiolabs.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/viraxbiolabs/files/theme/images/logo-300px.png Equisolve Investor Relations Suite https://ir.viraxbiolabs.com/news-events/press-releases/detail/86/virax-biolabs-ceo-james-foster-provides-shareholder-update Thu, 16 Jul 26 07:30:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/86/virax-biolabs-ceo-james-foster-provides-shareholder-update https://ir.viraxbiolabs.com/news-events/press-releases/detail/85/virax-biolabs-group-limited-announces-closing-of-exercise Fri, 10 Jul 26 16:05:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/85/virax-biolabs-group-limited-announces-closing-of-exercise https://ir.viraxbiolabs.com/news-events/press-releases/detail/84/virax-biolabs-group-limited-announces-exercise-of-preferred Thu, 09 Jul 26 13:35:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/84/virax-biolabs-group-limited-announces-exercise-of-preferred https://ir.viraxbiolabs.com/news-events/press-releases/detail/83/virax-biolabs-signs-multi-country-commercial-supply Thu, 09 Jul 26 07:30:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/83/virax-biolabs-signs-multi-country-commercial-supply https://ir.viraxbiolabs.com/news-events/press-releases/detail/82/virax-biolabs-group-limited-announces-1-for-25-share Wed, 24 Jun 26 09:00:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/82/virax-biolabs-group-limited-announces-1-for-25-share https://ir.viraxbiolabs.com/news-events/press-releases/detail/81/virax-biolabs-reports-positive-early-clinical-data-for Tue, 26 May 26 07:30:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/81/virax-biolabs-reports-positive-early-clinical-data-for https://ir.viraxbiolabs.com/news-events/press-releases/detail/80/virax-biolabs-ceo-james-foster-outlines-strategic Tue, 14 Apr 26 07:34:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/80/virax-biolabs-ceo-james-foster-outlines-strategic https://ir.viraxbiolabs.com/news-events/press-releases/detail/79/virax-biolabs-achieves-iso-certifications-laying Tue, 31 Mar 26 07:34:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/79/virax-biolabs-achieves-iso-certifications-laying https://ir.viraxbiolabs.com/news-events/press-releases/detail/78/virax-biolabs-group-limited-announces-closing-of-5-million Thu, 04 Dec 25 16:05:00 -0500 https://ir.viraxbiolabs.com/news-events/press-releases/detail/78/virax-biolabs-group-limited-announces-closing-of-5-million https://ir.viraxbiolabs.com/news-events/press-releases/detail/77/virax-biolabs-group-limited-announces-5-million-private Wed, 03 Dec 25 13:53:00 -0500 https://ir.viraxbiolabs.com/news-events/press-releases/detail/77/virax-biolabs-group-limited-announces-5-million-private